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A non-optimal receptor-binding specificity of avian influenza viruses is believed to hamper their replication in humans; however, the magnitude
of this restriction remains undefined. Here we generated recombinant viruses, R1 and R2, that differed solely by two amino acids in the receptor-
binding site of their hemagglutinin (HA). R1 harbored the original HA of the pandemic human virus A/HongKong/1/68 (H3N2), whereas R2was the
L226Q/S228G HA mutant with avian-virus-like receptor specificity. In differentiated cultures of human tracheo-bronchial epithelial cells, R1
preferentially infected non-ciliated cells, whereas R2 predominantly infected ciliated cells indicating that cell tropism was determined by the viral
receptor specificity. In the course of multi-cycle replication in these cultures, R2 spread less efficiently and grew to 2–10-fold lower titers than did R1.
These results for the first time estimate the level of receptor-dependent restriction of avian influenza viruses in human airway epithelium. They
support a theory that alteration of the receptor specificity of an avian virus could facilitate its human-to-human transmission.
© 2006 Elsevier Inc. All rights reserved.Keywords: Influenza; Pandemics; Host range; Reverse genetics; Sialic acid; Receptor specificity, Cell tropism; Replication efficiency, Human airway epithelial
culturesIntroduction
Influenza pandemics originate from birds which perpetuate
influenza A viruses with all known hemagglutinin (HA) and
neuraminidase (NA) subtypes (reviewed by Webster et al.,
1992; Cox and Subbarao, 2000). Fortunately, the avian viruses
cross the species barrier to humans only rarely. Although this
host-range restriction depends on many viral genes (reviewed
by Klenk and Rott, 1988; Baigent and McCauley, 2003; Webby
et al., 2004; Horimoto and Kawaoka, 2005), it can be partially
overcome by gene reassortment between avian and human
viruses. However, as any pandemic virus must carry the HA
from a non-human virus to escape the herd immunity in the
population, it is particularly important to understand what⁎ Corresponding author. Present address: Division of Virology, MRC National
Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA,
UK.
E-mail address: Mikhail.Matrosovich@nimr.mrc.ac.uk (M. Matrosovich).
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.11.030minimal changes in the avian HA are needed for the emergence
of a new pandemic strain.
A poor fit of avian viruses to cellular receptors in humans is
one potential HA-mediated restriction mechanism (reviewed by
Skehel and Wiley, 2000; Matrosovich et al., 2006). Avian
influenza viruses bind to cell-surface receptors containing
terminal sialyl–galactosyl residues linked by 2–3-linkage
[Neu5Ac(α2–3)Gal], whereas human viruses bind to receptors
which contain terminal α2–6–linked sialyl–galactosyl moieties
(Paulson, 1985; Nobusawa et al., 1991; Connor et al., 1994;
Matrosovich et al., 1997). The earliest studied virus strains from
the 1918, 1957, and 1968 pandemics displayed a human-virus-
like preference for 6-linked sialic acid receptors and decreased
binding to 3-linked receptors (Paulson, 1985; Connor et al.,
1994; Matrosovich et al., 2000; Kobasa et al., 2004; Glaser et
al., 2005). By contrast, H5N1 chicken influenza viruses that
cause sporadic cases of severe disease in humans since 1997
typically have an avian-virus-like receptor specificity (Matro-
sovich et al., 1999; Gambaryan et al., 2006) and are unable to
transmit efficiently from human to human. It is generally
Fig. 1. Receptor specificity (A) and cell tropism (B) of influenza viruses. (A)
Association constants (Kass) of virus complexes with sialylglycopolymers 3SL-
PAA and 6SLN-PAA (open and hatched bars, respectively). Higher Kass values
indicate stronger binding. (B) HTBE cultures were infected at multiplicity of
infection 0.2, fixed 8 h post infection and double-immunostained for viral
antigen and cilia of ciliated cells. Percentages of infected ciliated cells (open
bars) and infected non-ciliated cells (hatched bars) with respect to the total
amount of infected cells were determined as described in Materials and methods.
The abbreviations for the virus names are explained in the text.
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is a prerequisite for the highly effective replication and human-
to-human transmission which characterize pandemic virus
strains (reviewed by Cox and Subbarao, 2000; Horimoto and
Kawaoka, 2001; Baigent and McCauley, 2003; Matrosovich et
al., 2006). However, this theory has never been formally
proven, and neither magnitude of receptor-dependent restriction
on avian virus replication in humans, nor restriction mechan-
isms have been defined.
To address these questions, we employ differentiated cultures
of human tracheo-bronchial epithelial cells (HTBE) (Gray et al.,
1996). These cultures are pseudostratified and polarized, contain
ciliated, secretory, and basal cells, and resemble human airway
epithelium in vivo both morphologically and functionally (Gray
et al., 1996; Matrosovich et al., 2004; Thompson et al., 2006;
Ibricevic et al., 2006). Using this experimental system, we found
that human and avian viruses target different types of airway
epithelial cells in correlation with the expression levels of the
corresponding types of sialic acid receptors (Matrosovich et al.,
2004). Namely, at the initial stages of infection, human viruses
mainly infected non-ciliated cells whereas avian viruses
predominantly infected ciliated cells. After several cycles of
replication, the human virus produced large continuous foci of
infected cells that included both ciliated and non-ciliated cells.
By contrast, the avian virus formed less prominent foci remaining
mainly associated with ciliated cells (Matrosovich et al., 2004).
Thompson et al. (2006) used a similar in vitro model of human
airway epithelium and confirmed our findings. They noticed also
that avian viruses appeared to infect airway epithelial cells more
slowly than human viruses as avian virus antigen was not
detected at early times (6 h) post infection. Shinya et al. (2006)
reported that avian viruses in contrast to human viruses did not
infect pieces of surgically removed human airway epithelium.
These limited observations suggest that the replication of the
avian viruses in humans is restricted due to inefficient viral entry
and/or spread in the airway epithelium. However, as natural virus
isolates were used in these experiments, one could not
discriminate whether the observed differences in cell tropism
and replication were determined solely by different receptor
specificity of the viruses or by mechanisms that were dependent
on viral genes other than the HA gene.
In this study, we wished to overcome this problem and to
specify the level of receptor-dependent restriction on avian virus
replication in human airway epithelium. To this end, we used
reverse genetics to generate a pair of viruses that differed solely
by two amino acids in the HA receptor-binding site and had
either human-virus-like or avian-virus-like receptor specificity.
We next compared these viruses for the efficiency of their
replication in HTBE cultures.
Results and discussion
Generation of recombinant viruses with different receptor
specificity
To prepare recombinant viruses with either human-virus-like
or avian-virus-like receptor specificity, we used the eight-plasmid reverse genetics system described by Hoffmann et al.
(2000). Initially, we generated two viruses, R1 and R2, that
shared six genes of internal viral proteins from laboratory virus
strain A/WSN/33 (H1N1) and harbored the HA and NA genes
from the pandemic virus A/Hong Kong/1/68 (H3N2) (HK/68).
R1 contained original HA of the HK/68 virus; R2 differed from
R1 solely by mutations at HA codons 226 and 228 that reverted
the HA amino acid sequence (226L/228S) back to the consensus
sequence of the avian virus HA (226Q/228G). The choice of
these mutations was made based on the known essential role of
amino acids in position 226 and 228 in the receptor specificity of
H3 viruses and in the emergence of human pandemic virus from
an avian precursor (see Matrosovich et al., 2000 and references
therein).
After rescuing recombinant viruses and confirming the specific
identity of their HAs and NAs by sequencing, we tested R1 and R2
for their binding to a pair of biotinylated sialylglycopolymers,
3SL-PAA and 6SLN-PAA (Fig. 1A). Three natural viruses were
included in these experiments for a comparison, namely, original
HK/68 strain and two viruses used in our previous study
(Matrosovich et al., 2004), A/Mallard/Alberta/119/98 (H1N1)
(Dk/98) and A/Memphis/14/96-M (H1N1) (Mem/96-M). The
binding pattern of R1 was identical, within experimental error, to
that of the wild type HK/68, with either virus displaying a typical
human-virus-like preference for Neu5Ac(α2–6)Gal-containing
receptor 6SLN-PAA. Interestingly, both HK/68 and R1 were
able to bind to Neu5Ac(α2–3)Gal-containing glycopolymer 3SL-
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optimal receptor, 6SLN-PAA. This feature clearly distinguished
either virus from recent epidemic H1N1 virus Mem/96-M that did
not appreciably bind to 3SL-PAA. As expected, R2 displayed a
binding pattern that was similar to that of the duck virus Dk/98.
Namely, both viruses preferentially bound to 3SL-PAA and
displayed a much lower affinity for the 6-linked receptor analog
6SLN-PAA. This result agreed with the presence of the avian-
virus-like amino acids at the key positions 226 and 228 of the R2
HA. Thus, recombinant viruses R1 and R2 represented receptor
specificity of a human pandemic virus and of an aquatic bird virus,
respectively, in the otherwise identical genetic background.
Cell tropism of R1 and R2
To determine the type of cells targeted by R1 and R2 during
initial entry of the viruses into human airway epithelium, we
fixed HTBE cultures 8 h post infection, that is, after the first
cycle of viral replication. We immunostained fixed cultures for
cilia of ciliated cells and for viral antigen and determined
proportion of infected ciliated and non-ciliated cells (Fig. 1B).
The patterns of viral tropism to non-ciliated and ciliated cells
closely mirrored the patterns of viral binding to 6SLN-PAA and
3SL-PAA (compare Figs. 1A and B). Thus, three human
viruses, R1, HK/68, and Mem/96-M, which showed strong
binding to 6-linked receptor, preferentially infected non-ciliated
cells. R2 and Dk/98 preferentially infected ciliated cells, in aFig. 2. Patterns of infection by recombinant viruses R1 (A, C) and R2 (B, D). HTBE c
and double immunostained for virus (brown) and cilia of ciliated cells (gray). Objeccorrelation with strong binding of these viruses to 3SL-PAA and
much weaker binding to 6SLN-PAA.
Interestingly, R1 and HK/68 infected a higher percentage of
ciliated cells than did the recent human virus Mem/96-M. This
effect correlated with a higher affinity of HK/68 for 3-linked
receptor and with its lower affinity for 6-linked receptor as
compared to Mem/96-M. A similar phenomenon was observed
by Thompson et al. (2006), who reported that human H3N2/
1969 virus infected a higher proportion of ciliated cells in
airway epithelial cultures than did two human H3N2 viruses
from 1999 and 2000. We agree with these authors that a reduced
tropism of H3N2 virus isolates from 1968 and 1969 to non-
ciliated cells could reflect non-complete adaptation of these
pandemic virus strains to humans.
We next compared patterns of infection by R1 and R2 24 h
after viral inoculation. In the cultures infected with R1, we
observed formation of continuous foci of infected cells, which
included both non-ciliated and ciliated cells (Figs. 2A, C). By
contrast, R2 did not form continuous foci and was predomi-
nantly found in ciliated cells (Figs. 2B, D). These results
suggested that R1 spread in the cultures via infection of any
encountered cell irrespective of its type, whereas R2 spread less
efficiently and mainly via ciliated cells.
It has to be emphasized that neither R1 nor R2 had all-or-
none preference for a specific cell type. However, the avian-like
virus displayed a more restricted tropism than did the human
virus (see Fig. 2), the same pattern was observed previously inultures were infected at a multiplicity of infection 0.04, fixed 24 h post infection,
tives, 10× (A, B) and 40× (C, D).
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vich et al., 2004; Thompson et al., 2006). This correlation
confirms that distinctions in the cell tropism of natural viruses
were determined, at least in part, by the differences in the viral
receptor specificity.
Replication efficiency
To compare replication of R1 and R2, we inoculated HTBE
cultures with these viruses at identical multiplicity of infection
(MOI) and determined yields of the viral progeny in the apical
washings at different times post infection. In the first
experiment, we infected cultures at MOI 0.04 and followed
them up for 72 h. At 48 h, and 72 h, R2 grew to 2.2 and 4.8
lower titers, respectively, than did R1 (data not shown).
In the second experiment, we tested lower MOIs and
extended observation time to 120 h. In the cultures infected with
either 4000 or 400 plaque forming units of the virus (Figs. 3A,
B), the yield of R1 in the apical fluid progressively increased
during the whole observation period and finally reached 107
infectious units (IU) of the virus per 0.1 ml (about 3×107 IU per
culture). By contrast, the titers of R2 reached a plateau of about
106 IU/0.1 ml at 48 to 72 h post infection (PI). As a result, the
yield of R2 was about 10 times lower than that of R1 at 96 and
120 h PI. Because virus titers varied substantially in replicate
cultures infected with the lowest virus dose (40 PFU/culture;
MOI 0.00004), Fig. 3C shows results for individual replicates.
Among four R1-infected cultures, two cultures produced less
virus than the other two cultures during the first 4 days of
infection; however; at 120 h PI, the yield in all four cultures was
comparable (107 IU/0.1 ml). By this time, only two of four R2-
infected cultures yielded reasonably high amounts of virus
(∼106 IU/0.1 ml) which were still lower than those in R1-
infected cultures. In two other R2-infected cultures, no virus
could be detected during the first 3 days of infection, and the
titers were below 104 IU/0.1 ml at the end of the observation
period. To test whether a relatively high yield of R2 in two
infected cultures could be associated with selection of receptor-Fig. 3. Replication kinetics of R1 (open circles) and R2 (closed circles) in HTBE cultu
(MOI 0.0004) of the viruses, respectively. Each data point represents the mean±SD f
individual replicate cultures are shown. Star next to data point indicates that the difbinding mutants, we sequenced the complete HA genes of all
viruses harvested from R2-infected cultures 120 h PI. The
sequences were identical to that of the original R2 HA gene
ruling out our hypothesis about the selection of HA mutants. It
remains obscure, whether mutations in the neuraminidase and/
or other viral proteins could be responsible for a variable yield
of R2 in Fig. 3C. Although replicate cultures typically contained
similar average amounts of ciliated cells (as judged by
immunostaining for beta-tubulin), differentiated HTBE cultures
are inherently more heterogeneous than non-differentiated
laboratory cell lines. It seems likely, therefore, that at very
low MOI even minor variations of the cell composition and
mucus secretion in replicate cultures could be amplified into
significant variations in the viral yield. To corroborate the data
obtained with R1 and R2, which harbored 6 internal genes from
WSN/33, we generated a new pair of recombinant viruses, R1-
HK and R2-HK, with all their genes derived from HK/68. R1-
HK thus represented an exact recombinant replica of the human
pandemic virus, whereas R2-HK modeled the putative progen-
itor of this virus with an avian-virus-like receptor specificity.
We compared yields of R1-HK and R2-HK in HTBE cultures
72 h post infection (Table 1). In the first two experiments, R2-
HK produced about 4 to 6 times less infectious progeny than did
R1-HK. These results agreed with the data obtained for the R1–
R2(WSN) pair of viruses (see Fig. 3). In the third experiment,
we wished to model more closely conditions of the in vivo
infection in the airway epithelium by preserving the integrity of
the mucus blanket. To minimize disturbance and dilution of the
mucus, we neither washed the cultures before virus inoculation,
nor removed the inoculum after viral adsorption. Also, we
reduced the size of inoculum to 20 μl and incubated infected
cultures at air–liquid interface throughout the whole experi-
ment. Under these conditions, the yield of R1-HK was less than
10% of its yield in the previous two experiments demonstrating
substantial interference of the mucus blanket with the viral
infection. For each of the three infection doses used, R2-HK
replicated to lower titers than did R1-HK. In the case of two
higher doses (1000 and 100 PFU per culture), the differenceres. (A and B) Cultures were infected with 4000 PFU (MOI 0.004) and 400 PFU
rom 4 cultures. (C) Cultures were infected with 40 PFU (MOI 0.00004). Data for
ference between titers of R1 and R2 is statistically significant (p<0.05).
Table 1
Yield of recombinant viruses R1-HK and R2-HK at the apical side of HTBE
cultures 72 h post infection
Experimenta MOI, PFU
per culture





1 200 170 (46) 39 (5.4) 4.4b
2 2000 48 (6.4) 7.6 (2.2) 6.3c
200 66 (3.6) 10.8 (3.1) 6.1c
3 1000 5.7 (2.5) 2.4 (0.62) 2.4d
100 4.7 (1.8) 3.0 (2.7) 1.6
10 2.5e (3.9) 0.0058f (0.0017) 430
aEach of the 3 experiments was performed on a different day using 4 replicate
cultures for each MOI. The first two experiments were done as described in
Materials and methods. Experiment No. 3 was done with the following
modifications: we did not wash the cultures before infection, inoculated them
with 20 μl of viral suspensions, and did not remove the inoculum.
b,c,dp<0.002 (b), p<0.0001 (c), and p<0.05 (d) (p-value for comparison between
yields of R1-HK and R2-HK, unpaired t-test).
e,fThe yields in individual replicate cultures were (e) 0.03, 0.051, 1.7, 8.2 and (f)
0.0044, 0.0045, 0.0063, 0.008.
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distinction between these viruses was observed in the cultures
infected with 10 PFU. The yield of R1-HK varied significantly
in individual infected cultures (from 3×104 to 8×106 IU);
however, the averaged yield was comparable to those in cultures
infected at higher MOI. By contrast, although all 4 cultures
inoculated with 10 PFU of R2-HK became infected, the yield of
viral progeny was decreased more than 100-fold compared to
cultures infected with 100 and 1000 PFU.
Taken together, these experiments demonstrate that recom-
binant viruses with the avian-virus-like receptor specificity
replicate in human airway epithelial cultures to lower titers than
do their human-virus-like counterparts. Furthermore, at low
multiplicity (less than 100 PFU per culture), the avian-like
viruses failed to establish efficient infection. The mechanisms of
these effects remain to be elucidated. The most obvious
differences between R1 and R2 in these cultures observed so
far were distinctive cell tropism and spread (Figs. 1 and 2). It is
possible, therefore, that R2 replicates to lower titers than does
R1 because R2 cannot infect a substantial fraction of airway
epithelial cells, non-ciliated cells, which are susceptible to R1.
Other potential mechanisms could be a lower virus production
in ciliated cells as compared to non-ciliated cells, a slower viral
entry into airway epithelium (Thompson et al., 2006), or a poor
release of virus progeny from infected cells.
Our results on viral replication in HTBE cultures predict that
under conditions of natural human infection the virus with
avian-virus-like receptor specificity will be shed in lower titers
and in addition will be less contagious than the virus with
human-virus-like specificity. Although the differences between
R1 and R2 in yield and infectivity were not striking, they appear
to be significant enough to hamper or even prevent the human-
to-human transmission of the virus with the avian-like HA.
Thus, our data agree with the theory that alteration of receptor
specificity will facilitate the emergence of a new pandemic
virus.On the other hand, the fact that replication of R2 and R2-HK
reassortant viruses was only moderately impaired in HTBE
cultures argues against a popular opinion about inability of
avian viruses to replicate in the human upper respiratory tract
due to a lack of corresponding receptors. Clearly, receptor
specificity is not the only factor responsible for the relatively
rare cases of human infections with avian viruses.
Materials and methods
Wild-type and recombinant viruses
A/Hong Kong/1/68 (H3N2) (HK/68) (Brown et al., 2001)
was provided by Earl Brown at University of Ottawa, Ottawa,
Canada. Robert Webster at St. Jude Children's Research
Hospital, Memphis, TN provided the clinical human isolate in
MDCK cells A/Memphis/14/96-M (H1N1) (Mem/96-M), the
duck virus A/Mallard/Alberta/119/98 (H1N1) (Dk/98), and
antisera against whole H3N2 and H1N1 viruses. We prepared
and aliquoted virus stocks after making one passage of the
human viruses in MDCK cells and of the duck virus in
embryonated hen's eggs.
Eric Hoffmann and Robert Webster at St. Jude Children's
Research Hospital, Memphis, TN, kindly provided Pol I/Pol II
expression vector pHW2000 (Hoffmann et al., 2000) and eight
pHW2000-based plasmids for the rescue of A/WSN/33 (H1N1)
virus.
We amplified each gene segment of HK/68 virus by RT-PCR
from isolated RNA using a set of universal primers (Hoffmann
et al., 2001) and ligated the products into the pHW2000 plasmid
as described previously (Hoffmann et al., 2000, 2001). To
generate amino acid substitutions L226Q and S228G in the HA,
we used site-directed mutagenesis kit (QuikChange, Strata-
gene). Double-base mutations at either codon of the HA gene
were introduced to prevent reversion of the sequence. We
confirmed the identity of all plasmids by sequencing.
We generated recombinant viruses using previously de-
scribed protocol of the eight plasmid reverse genetics system
(Hoffmann et al., 2000). In brief, we transfected 293T cells with
a mixture of eight plasmids encoding each viral gene segment
with Lipofectamine 2000 (Invitrogen) as recommended by the
manufacturer. Six hours later, we replaced the transfection
medium with DMEM containing 0.1% BSA. After 2 days of
incubation, we treated supernatants collected from transfected
293T cells with TPCK-trypsin and amplified rescued viruses in
MDCK cells.
We prepared four recombinant viruses. Two of them, R1 and
R2, contained the HA and NA genes from the A/Hong Kong/1/
68 virus and the remaining gene segments from A/WSN/33.
The other two viruses, R1-HK and R2-HK, contained all
8 genes from the HK/68 virus. For either pair of viruses, the R1
counterpart contained the original H3 HA, and the R2
counterpart contained the HA with the L226Q/S228G muta-
tions. We aliquoted the R1 and R2 viruses directly after rescue
without plaque purification. We plaque purified R1-HK and R2-
HK twice in MDCK cells before preparing aliquots. The
infectivity of all aliquoted viruses was characterized by plaque
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NAs was confirmed by sequencing.
Receptor-binding assay
Synthetic biotinylated sialylglycopolymers, 3SL-PAA and
6SLN-PAA (carrying the Neu5Ac(α2–3)Gal(β1–4)Glc and
Neu5Ac(α2–6)Gal(β1–4)GlcNAc moieties, respectively) were
kindly provided by Alexander Tuzikov and Nikolai Bovin at
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry,
Moscow, Russia. We determined the binding of these polymers
to the viruses using a solid-phase assay and calculated
association constants of virus–polymer complexes as previously
described (Matrosovich et al., 2000).
Airway epithelial cultures
Differentiated HTBE cultures were prepared as described
before (Gray et al., 1996; Matrosovich et al., 2004). In brief, we
purchased primary human tracheo-bronchial cells from Clo-
netics (Cambrex), expanded them on plastic, and stored in
aliquots. We propagated these passage 1 cells on membrane
supports (12-mm Transwell-Clear, Corning Inc.) at an air–
liquid interface (ALI) in serum-free, hormone- and growth
factor-supplemented growth medium (GM) (Gray et al., 1996).
Fully differentiated 5- to 7-week-old cultures prepared from the
same lot of commercial primary cells isolated from a single
donor were used for all experiments.
Viral infections in HTBE cultures
We studied cell tropism and virus spread as previously
described (Matrosovich et al., 2004). Briefly, we washed the
cultures 10 times with the DMEM to remove accumulated
mucins and incubated the apical sides of the cultures with 0.2 ml
of viral dilutions in the complete growth medium. After 1 h of
incubation, we removed the viruses and incubated cultures at
35° under ALI conditions for either 7 h or 23 h. We next fixed
the cultures with 4% paraformaldehyde for 30 min at 4° and
double-immunostained them for cilia of ciliated cells and for
viral antigen using antibodies against beta-tubulin and whole
viruses, respectively, and peroxidase-labeled secondary anti-
bodies. Stained cultures were mounted and observed en face
using a Nikon Optiphot-2 microscope equipped with a CCD
camera. For cell counting, we used a 100× objective with oil
immersion. In microscopic fields containing between 5 and
20% ciliated cells with respect to the total amount of superficial
cells, each infected cell was classified as either ciliated, non-
ciliated, or as undefined. Percentages of ciliated and non-
ciliated infected cells with respect to the total amount of infected
cells were calculated. Twenty-five to thirty-five fields were
analyzed per sample, and the results were averaged.
To characterize replication kinetics of R1 and R2 (i.e.,
recombinant viruses with internal genes from WSN/33 virus),
we infected washed cultures with 40 to 40,000 plaque-forming
units of the viruses in 0.2 ml GM. We removed the inoculum
following 1-h incubation, overlaid apical sides of infectedcultures with 0.1 ml fresh GM, and incubated them for 72 to
120 h. We collected aliquots of the apical medium at 24 h
intervals by adding 0.2 ml fresh GM to the apical compartment,
incubating the cultures for 15 min, and removing 0.2 ml
aliquots. We stored the aliquots at −80 ° until the end of
experiment and analyzed them simultaneously for infectious
virus yields by titration in MDCK cells as described below.
We compared yields of R1-HK and R2-HK 72 h post infection.
In two of the three experiments performed on different days, we
infected washed cultures with 0.2 ml viral suspensions, removed
the inoculum 1 h later, and incubated the cultures without adding
the growth medium to the apical compartment (ALI conditions).
Following 72-h incubation, we added 0.2 ml fresh GM to the
apical site and collected the virus material 1 h later. The third
experiment differed from the first two experiments as follows. We
did not wash the cultures before infection. We applied 20 μl per
culture of viral suspensions and incubated the cultures at ALI for
3 days without removing the inoculum.
Virus titration in MDCK cells
MDCK cells grown in 96-well plates (Costar) were washed 3
times with minimal essential medium and inoculated with
0.1 ml of 10-fold dilutions of the viruses in DMEM
supplemented with 0.1% BSA (4 replicates per dilution).
Eight to sixteen hours post-inoculation, the cells were fixed with
4% paraformaldehyde for 30 min at 4°. Fixed cultures were
immunostained for the expression of influenza virus nucleo-
protein (NP) by incubating for 1 h with anti-NP monoclonal
antibodies (kindly provided by Alexander Klimov at Centers for
Disease Control, USA) followed by 1 h of incubation with
peroxidase-labeled anti-mouse antibodies (Sigma) and 30 min
of incubation with True Blue substrate (KPL). Ten-percent
horse serum plus 0.05% Tween 80 in PBS was used for the
preparation of working dilutions of immuno-reagents. Numbers
of infected cells per well were counted for the virus dilution that
produced from 30 to 300 infected cells per well and recalculated
into numbers of infectious virus units (IU) per 0.1 ml of the
original undiluted virus suspensions.
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